Correlation Between Sutro Biopharma and Ikena Oncology

Can any of the company-specific risk be diversified away by investing in both Sutro Biopharma and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sutro Biopharma and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sutro Biopharma and Ikena Oncology, you can compare the effects of market volatilities on Sutro Biopharma and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sutro Biopharma with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sutro Biopharma and Ikena Oncology.

Diversification Opportunities for Sutro Biopharma and Ikena Oncology

0.52

Correlation Coefficient

Sutro Biopharma  Ikena Oncology

Very weak diversification

The 3 months correlation between Sutro and Ikena is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Sutro Biopharma and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Sutro Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sutro Biopharma are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Sutro Biopharma i.e., Sutro Biopharma and Ikena Oncology go up and down completely randomly.

Pair Corralation between Sutro Biopharma and Ikena Oncology

Given the investment horizon of 90 days Sutro Biopharma is expected to generate 3.65 times more return on investment than Ikena Oncology. However, Sutro Biopharma is 3.65 times more volatile than Ikena Oncology. It trades about 0.0 of its potential returns per unit of risk. Ikena Oncology is currently generating about -0.01 per unit of risk. If you would invest  147.00  in Sutro Biopharma on March 6, 2025 and sell it today you would lose (56.00) from holding Sutro Biopharma or give up 38.1% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Sutro Biopharma  vs.  Ikena Oncology

Sutro Biopharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sutro Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Sutro Biopharma is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Ikena Oncology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ikena Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Ikena Oncology is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Sutro Biopharma and Ikena Oncology

The main advantage of trading using opposite Sutro Biopharma and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sutro Biopharma position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.

The idea behind Sutro Biopharma and Ikena Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.